Publications by authors named "Bryan Sherman"

Claim this Profile
R
Resilient anatomy and local plasticity of naive and stress haematopoiesis.
Qingqing Wu, Jizhou Zhang, Sumit Kumar, Siyu Shen, Morgan Kincaid, Bryan E Sherman

Nature· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproductive outcomes after pregnancy-induced displacement of preexisting microchimeric cells.
Tzu-Yu Shao, Jeremy M Kinder, Gavin Harper, Giang Pham, Yanyan Peng, Bryan E Sherman

Science· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma.
Cheng-Wen Lin, Bryan Sherman, Lori A Moore, Carmen L Laethem, Da-Wen Lu

J Ocul Pharmacol Ther· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma.
Jill M Sturdivant, Susan M Royalty, Cheng-Wen Lin, Lori A Moore, Jeffrey D Yingling, Bryan Sherman

Bioorg Med Chem Lett· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of potent and selective beta3 adrenergic receptor agonists containing heterobiaryl carboxylic acids.
Barry G Shearer, Esther Y Chao, David E Uehling, David N Deaton, Conrad Cowan, Bryan W Sherman

Bioorg Med Chem Lett· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biarylaniline phenethanolamines as potent and selective beta3 adrenergic receptor agonists.
David E Uehling, Barry G Shearer, Kelly H Donaldson, Esther Y Chao, David N Deaton, Bryan W Sherman

J Med Chem· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.
Jason D Speake, Frank Navas, Michael J Bishop, Deanna T Garrison, Eric C Bigham, Bryan W Sherman

Bioorg Med Chem Lett· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.
Stephen J Hodson, Eric C Bigham, Deanna T Garrison, Michael J Gobel, Paul E Irving, Bryan W Sherman

Bioorg Med Chem Lett· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.
Stephen J Hodson, Michael J Bishop, Jason D Speake, Frank Navas, Deanna T Garrison, Bryan W Sherman

J Med Chem· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres.
David E Uehling, Kelly H Donaldson, David N Deaton, Clifton E Hyman, Elizabeth E Sugg, Bryan W Sherman

J Med Chem· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis